Hyundai Pharm (004310) - Cash Flow Conversion Efficiency

Latest as of February 2026: 0.001x

Based on the latest financial reports, Hyundai Pharm (004310) has a cash flow conversion efficiency ratio of 0.001x as of February 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩188.28 Million ≈ $127.59K USD) by net assets (₩134.81 Billion ≈ $91.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Hyundai Pharm net asset quality index to measure how much of total assets are equity-financed.

Hyundai Pharm - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Hyundai Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 004310 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Hyundai Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hyundai Pharm ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
QRF SCA BR:QRF	-0.001x
Grupo Sports World S.A.B. de C.V MX:SPORTS	0.129x
CJ CheilJedang Corp KO:097955	0.068x
Global Fashion Group SA XETRA:GFG	0.048x
Trigg Minerals Ltd AU:TMG	-0.588x
MPH Health Care AG F:93M1	-0.003x
Global Fashion Group S.A F:GFG	-0.222x
Zeotech Ltd AU:ZEO	-0.080x

Annual Cash Flow Conversion Efficiency for Hyundai Pharm (2010–2025)

The table below shows the annual cash flow conversion efficiency of Hyundai Pharm from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Hyundai Pharm.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-11-30	₩82.10 Billion ≈ $55.64 Million	₩-123.29 Million ≈ $-83.55K	-0.002x	+95.00%
2024-11-30	₩79.07 Billion ≈ $53.59 Million	₩-2.37 Billion ≈ $-1.61 Million	-0.030x	+44.10%
2023-11-30	₩84.66 Billion ≈ $57.37 Million	₩-4.55 Billion ≈ $-3.08 Million	-0.054x	-139.98%
2022-11-30	₩86.56 Billion ≈ $58.66 Million	₩11.62 Billion ≈ $7.88 Million	0.134x	+126.60%
2021-11-30	₩86.60 Billion ≈ $58.69 Million	₩5.13 Billion ≈ $3.48 Million	0.059x	-50.56%
2020-11-30	₩90.14 Billion ≈ $61.09 Million	₩10.80 Billion ≈ $7.32 Million	0.120x	+50.79%
2019-11-30	₩87.58 Billion ≈ $59.35 Million	₩6.96 Billion ≈ $4.72 Million	0.079x	+200.09%
2018-11-30	₩107.00 Billion ≈ $72.52 Million	₩2.83 Billion ≈ $1.92 Million	0.026x	+231.16%
2017-11-30	₩98.10 Billion ≈ $66.48 Million	₩-1.98 Billion ≈ $-1.34 Million	-0.020x	+26.42%
2016-11-30	₩100.08 Billion ≈ $67.82 Million	₩-2.75 Billion ≈ $-1.86 Million	-0.027x	-134.94%
2013-11-30	₩101.21 Billion ≈ $68.59 Million	₩7.95 Billion ≈ $5.39 Million	0.079x	+390.34%
2012-11-30	₩99.69 Billion ≈ $67.56 Million	₩-2.70 Billion ≈ $-1.83 Million	-0.027x	-145.03%
2011-11-30	₩104.32 Billion ≈ $70.69 Million	₩6.27 Billion ≈ $4.25 Million	0.060x	+107.53%
2010-11-30	₩92.50 Billion ≈ $62.69 Million	₩2.68 Billion ≈ $1.82 Million	0.029x	--

About Hyundai Pharm

KO:004310 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$112.30 Million

₩165.71 Billion KRW

Market Cap Rank

#18701 Global

#832 in Korea

Share Price

₩5360.00

Change (1 day)

+5.72%

52-Week Range

₩3545.00 - ₩14340.00

All Time High

₩14340.00